JP2010533707A5 - - Google Patents

Download PDF

Info

Publication number
JP2010533707A5
JP2010533707A5 JP2010516705A JP2010516705A JP2010533707A5 JP 2010533707 A5 JP2010533707 A5 JP 2010533707A5 JP 2010516705 A JP2010516705 A JP 2010516705A JP 2010516705 A JP2010516705 A JP 2010516705A JP 2010533707 A5 JP2010533707 A5 JP 2010533707A5
Authority
JP
Japan
Prior art keywords
deoxy
branched
linear
prostaglandin compound
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010516705A
Other languages
English (en)
Japanese (ja)
Other versions
JP5390519B2 (ja
JP2010533707A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2008/063222 external-priority patent/WO2009011449A2/en
Publication of JP2010533707A publication Critical patent/JP2010533707A/ja
Publication of JP2010533707A5 publication Critical patent/JP2010533707A5/ja
Application granted granted Critical
Publication of JP5390519B2 publication Critical patent/JP5390519B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010516705A 2007-07-19 2008-07-16 11−デオキシ−プロスタグランジン化合物を含む医薬組成物およびその安定化方法 Expired - Fee Related JP5390519B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92994807P 2007-07-19 2007-07-19
US60/929,948 2007-07-19
PCT/JP2008/063222 WO2009011449A2 (en) 2007-07-19 2008-07-16 Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013211759A Division JP2014001247A (ja) 2007-07-19 2013-10-09 11−デオキシ−プロスタグランジン化合物を含む医薬組成物およびその安定化方法

Publications (3)

Publication Number Publication Date
JP2010533707A JP2010533707A (ja) 2010-10-28
JP2010533707A5 true JP2010533707A5 (enExample) 2013-05-09
JP5390519B2 JP5390519B2 (ja) 2014-01-15

Family

ID=39720491

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010516705A Expired - Fee Related JP5390519B2 (ja) 2007-07-19 2008-07-16 11−デオキシ−プロスタグランジン化合物を含む医薬組成物およびその安定化方法
JP2013211759A Pending JP2014001247A (ja) 2007-07-19 2013-10-09 11−デオキシ−プロスタグランジン化合物を含む医薬組成物およびその安定化方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013211759A Pending JP2014001247A (ja) 2007-07-19 2013-10-09 11−デオキシ−プロスタグランジン化合物を含む医薬組成物およびその安定化方法

Country Status (14)

Country Link
US (2) US8969324B2 (enExample)
EP (2) EP2327398A3 (enExample)
JP (2) JP5390519B2 (enExample)
KR (1) KR101485212B1 (enExample)
CN (2) CN101808623B (enExample)
AU (1) AU2008276840B2 (enExample)
BR (1) BRPI0814115B8 (enExample)
CA (1) CA2691995C (enExample)
IL (1) IL203064B (enExample)
MX (1) MX339727B (enExample)
NZ (2) NZ595270A (enExample)
RU (3) RU2506072C2 (enExample)
TW (2) TWI446912B (enExample)
WO (1) WO2009011449A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101410097A (zh) * 2006-01-24 2009-04-15 株式会社·R-技术上野 软明胶胶囊制剂
CN107903173A (zh) * 2011-08-05 2018-04-13 苏坎波公司 治疗精神分裂症的方法
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
JP6580414B2 (ja) * 2015-08-07 2019-09-25 小林製薬株式会社 生薬末含有錠剤
US10716544B2 (en) 2015-10-08 2020-07-21 Zmk Medical Technologies Inc. System for 3D multi-parametric ultrasound imaging
CN108619107A (zh) * 2018-05-28 2018-10-09 青海制药厂有限公司 一种含鲁比前列酮的软胶囊及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE572839A (enExample) * 1958-02-12
JPS5350141A (en) * 1976-10-18 1978-05-08 Ono Pharmaceut Co Ltd Stabilization of prostaglandin and prostaglandin analogues
US4310543A (en) 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
US4301175A (en) * 1980-12-29 1981-11-17 The Upjohn Company E-Type prostaglandin compositions
US4431833A (en) * 1982-12-27 1984-02-14 American Cyanamid Company Prostaglandin and hydroxylated fatty acid ester formulations
KR920007569B1 (ko) * 1984-11-30 1992-09-07 쥬우가이 세이야꾸 가부시끼가이샤 프로스타글란딘 e 유도체의 안정한 제제의 제조방법
US5166174A (en) * 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US6183466B1 (en) * 1998-08-21 2001-02-06 Alza Corporation Dosage form comprising a capsule
EP1220849B1 (en) * 1999-10-15 2004-05-19 Sucampo AG Bicyclic compounds composition and method for stabilizing the same
ATE387191T1 (de) * 2002-04-25 2008-03-15 Banner Pharmacaps Inc Kaubare weichkapsel
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
DE602004015507D1 (de) * 2004-02-17 2008-09-11 Symrise Gmbh & Co Kg Überzogene, sphärische, nahtlose, gefüllte kapseln
BRPI0607084A2 (pt) * 2005-01-27 2009-08-04 Sucampo Ag uso de um composto 11-desóxiprostaglandina, composição compreendendo o mesmo, e composto
TWI432201B (zh) 2005-03-04 2014-04-01 Sucampo Ag 11-去氧基-前列腺素化合物用於治療週邊血管疾病之用途
CN101410097A (zh) 2006-01-24 2009-04-15 株式会社·R-技术上野 软明胶胶囊制剂

Similar Documents

Publication Publication Date Title
JP2010533707A5 (enExample)
JP4332316B2 (ja) 二環式化合物組成物およびその安定化方法
JP2009114217A5 (enExample)
JP4783794B2 (ja) 軟ゼラチンカプセル製剤
RU2018113296A (ru) Фармацевтическая композиция, содержащая 11-дезокси-простагландиновое соединение и способ стабилизации этого соединения
JPH0460973B2 (enExample)
JP2013518832A5 (enExample)
JP5734331B2 (ja) 二環式化合物を含む医薬組成物およびその二環式化合物の安定化方法
MXPA04007023A (es) Agentes hipnoticos sedantes de corta accion para anestesia y sedacion.
CA2502293A1 (en) Ship 1 modulators
JP2006506381A5 (enExample)
JP2014511825A5 (enExample)
JP2007518685A5 (enExample)
JP2008528440A5 (enExample)
JP2004519412A5 (enExample)
RU2017137960A (ru) Применение тиаоксосоединений для уменьшения содержания аро сз
JP2011509237A5 (enExample)
JP2016528165A5 (enExample)
JP2008511541A5 (enExample)
JP2014237711A5 (enExample)
JP2014527048A5 (enExample)
KR880001561A (ko) 유효한 치료성을 갖는 신규 8-(저급알킬)비시클로[4.2.0] 옥탄 유도체
RU2014108423A (ru) Способ лечения шизофрении
JP2013504520A5 (enExample)
JP2015514681A5 (enExample)